BSc (Hons), MBChB, MRCP, DPhil
Consultant Hepatologist & Senior Lecturer in Gastroenterology & Hepatology, JR Hospital, Oxford.
- Wellcome Trust Clinical Research Fellow, University of Oxford, Oxford, UK.
Emma Culver is a Consultant Hepatologist and Senior Lecturer at the Translational Gastroenterology Unit, John Radcliffe Hospital in Oxford, with an interest in immune mediated liver diseases including IgG4-related disease, autoimmune hepatitis, primary sclerosing cholangitis and primary biliary cholangitis.
She set up and co-ordinated the IgG4-RD Study in Oxford during her Academic Clinical Fellowship (2010) and Wellcome Trust Clinical Research Fellowship (DPhil 2011-2015). Her PhD work focussed on the natural history and immunological drivers of IgG4-RD. Her NIHR BRC Oxford Clinical Lectureship (2018-) centred on the fibrotic mechanisms of this disease. She runs the Oxford Autoimmune Liver Disease service with specialist IgG4, PSC and autoimmune liver clinics, and runs a regional autoimmune liver disease MDT, and a national Oxford-London IgG4 MDT.
She is Chair of UK IgG4 and on the Steering Committee for UK PSC, and a member of the International IgG4-RD, PSC and AIH Study Groups.
Emerging therapy options for IgG4-related disease.
Lanzillotta M. et al, (2021), Expert review of clinical immunology, 17, 471 - 483
The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases.
Cargill T. and Culver EL., (2021), Frontiers in immunology, 12
Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease'.
Peters RJR. et al, (2020), Annals of the rheumatic diseases
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
Culver EL. et al, (2020), Liver international : official journal of the International Association for the Study of the Liver, 40, 2744 - 2757
Divergent chemokine receptor expression and the consequence for human IgG4 B cell responses.
Unger P-PA. et al, (2020), European journal of immunology, 50, 1113 - 1125